期刊文献+

重组青霉素G酰化酶拆分制备(S)-邻氯苯甘氨酸 被引量:1

Preparation of (S)-2-chlorophenyl glycine using penicillin G acylase
下载PDF
导出
摘要 对产青霉素G酰化酶的重组枯草芽胞杆菌发酵产酶条件进行优化,确定优化后的发酵条件:可溶性淀粉10g/L、蛋白胨12 g/L、酵母粉3 g/L、NaCl 10 g/L;pH 7.5、培养温度37℃、装液量80 mL(500 mL三角瓶)、培养28 h,青霉素G酰化酶的表达水平由最初的7.34 U/mL提高至18.23 U/mL。以表达青霉素G酰化酶的枯草芽胞杆菌发酵液为酶源,在水相中对映选择性催化N-苯乙酰-(R,S)-邻氯苯甘氨酸制备(S)-邻氯苯甘氨酸,当底物浓度为100mol/L时转化4 h,转化率达44.2%。对底物浓度为80 mmol/L反应液中的(S)-邻氯苯甘氨酸进行分离,达到理论收率的94.29%(以N-苯乙酰-(R,S)-邻氯苯甘氨酸的0.5倍摩尔量为理论产率),e.e.值大于99.9%。170℃条件下,N-苯乙酰-(R)-邻氯苯甘氨酸与苯乙酸共熔消旋为N-苯乙酰-(R,S)-邻氯苯甘氨酸可用于循环拆分。 Cultivation conditions of recombinant Bacillus subtilis expressing penicillin G acylase were investigated. The optimized fermentation conditions were as follows: soluble starch 10. 0 g/L, peptone 12 g/L,yeast extract 3 g/L,and NaCl 10 g/L;fermentation temperature 37 ℃ ,flask column 80 mL in 500 mL flask,and inoculation time 28 h. Under the optimal conditions, the penicillin G acylase activity increased from 7. 34 U/mL to 18. 23 U/mL. (S)-2-chlorophenylglycine was resolved by enantioselective catalytic of N-phenylacetic-(R,S)-2-chlorophenylglycine in aqueous phase for the presence of penicillin G acylase from recombinant Bacillus subtilis. When the substrate concentration was 100 mmol/L and the reaction time was 4 h, the conversion reached 44.2%. (S)-2-chlorophenylglycine was isolated from the reaction mixture of 80 mmol/L substrate concentration in enantiomerically pure form ( 〉 99. 9% e. e. ) and 94. 29% yield. N-phenylacetic-(R)-2-chlorophenylglycine was racemized at 170 ℃ for recycling.
出处 《生物加工过程》 CAS CSCD 2013年第1期5-11,共7页 Chinese Journal of Bioprocess Engineering
基金 国家重点基础研究发展计划(973计划)资助(2011CB710804)
关键词 青霉素G酰化酶 (S)-邻氯苯甘氨酸 拆分 优化 penicillin G acylase (S) -2-chlorophenylglycine resolution optimization
  • 相关文献

参考文献22

  • 1Bousquet A, Muslino A. Hydroxyacetic ester derivatives, preparation method and use as synthesis intermediates: US, 6573381BI [ P]. 2003-06-03.
  • 2Herbert J M, Savi P, Maffrand J P. Biochemical and pharmacological properties of clopidogrel: a new ADP receptor antagonist [ J ]. Eur Heart J Suppl, 1999,1 (Sup) :3140.
  • 3Campo G, Fileti L, de Cesare N, et al. Long-term clinical outcome based on aspirin and clopidogrel responsiveness status after elective percutaneous coronary intervention [ J ]. J Am College Cardiol, 2010,56 ( 18 ) : 1447-1455.
  • 4王威,薛亚平,郑裕国.氯吡格雷生产技术研究进展[J].现代化工,2011,31(5):30-34. 被引量:3
  • 5Lin S S-S, Chen C C. Process for preparation of 2- chlorophenylglyeine derivatives and enantiomerically separation: US ,20040176637 [ P]. 2004-09-09.
  • 6梁美好,沈正荣.(+)-氯吡格雷的合成工艺改进[J].中国药物化学杂志,2007,17(3):163-165. 被引量:12
  • 7杨华铮,宋洪海.硫酸氢氯吡格雷的制备方法:中国,101121720A[P].2008-02-13.
  • 8沈立新,袁利,刘福双,等.一种新的制备氯吡格雷及其盐的方法:中国,101787032A[P].2010-07-28.
  • 9Maheshwari K K, Sarma R K, Joshi S V, et al. Racemization of optically active 2-substituted phebyl glycine esters : US,20040073057[P].2004-04-15.
  • 10Battula S R. A process for resolution of methylamino (2- chloprophenyl) acetate : WO, 2006003671 A1 [ P ]. 2006 -01-12.

二级参考文献45

  • 1梁美好,沈正荣.(+)-氯吡格雷的合成工艺改进[J].中国药物化学杂志,2007,17(3):163-165. 被引量:12
  • 2Herbert J M, Savi P, Maffrand J P. Biochemical and pharmacological properties of clopidogre : A new ADP receptor antagonist [ J ]. European Heart Journal, 1999,20 ( Suppll A ) : 31 - 40.
  • 3Campo G, Fileti L, Nicoletta de Cesare, et al. Long-term clinical outcome based on aspirin and clopidogrel responsiveness status after elective percutaneous coronary intervention [ J ]. Journal of the American College of Cardiology ,2010,56 : 1447 - 55.
  • 4Sanofi S A. Thieno [ 3,2-c ] pyridine derivatives and their theutic application : US ,4529596 [ P]. 1985 - 07 - 16.
  • 5Sanofi. Dextro-rotatory enantiomer of methyl alpha-5 ( 4,5,6,7-tetrahydro(3,2-c) thieno pyridyl) (3-chlorophenyl)-aletate and the pharmaceutical compositions containing it: US, 4847265 [ P ]. 1989 -07 -11.
  • 6Kim S D,Kang W,Lee H W,et al. Bioequivalence and tolerability of two clopidogrel salt preparations, besylate and bisulfate:A randomized,open label, crossover study in healthy Korean male subjects [ J ]. Clinical Therapeutics,2009,31 (4) :793 - 803.
  • 7Sanofi. Process for the preparation of a-bromo-phenylacetic acids: US,5036156[ P]. 1991 -07 -30.
  • 8Sanofi Sa Bakonyi Maria. New Intermediates for clopidogrel and analogs and process for their preparation: WO ,9851681 [ P]. 1998 - 11 -19.
  • 9Wang L X,Shen J F. Synthetic improvements in the preparation of clopidogrel [ J ]. Organic Process Research & Development, 2007, 11:487 - 489.
  • 10Teva Pharmaceutical Industries Ltd. Racemization and enantiomer separation of clopidogrel : US ,6800759 [ PI. 2004 - 12 - 05.

共引文献17

同被引文献25

  • 1马玉卓,梅文杰,刘鹰翔,周玉平,佘志刚.dl-邻氯苯基甘氨酸的合成研究[J].广东药学院学报,2006,22(3):239-240. 被引量:1
  • 2梁美好,沈正荣.(±)邻氯苯甘氨酸的拆分工艺研究[J].浙江省医学科学院学报,2007,18(1):26-27. 被引量:1
  • 3张生勇 郭建权.不对称催化反应[M].北京:科学出版社,2002.93.
  • 4Descamps M, Lhum, Radisson J, et al. Proces for preparation o{ N-phenylacetyI derivative o{ tetrahydrothieno (3,2-c] pyri- dine and intermediate of synthesis [P]. EP 0466569 A1, 1991- 07-08.
  • 5Garcia M J, Azerad R. Production of ring-substituted D phenyl- glycines by microbial or enzymatic hydrolysis/deraeemisation of the corresponding DE hydantoins (J:. Tetrahedron: Asymme- try, 1997, 8 (1)= 85-92.
  • 6Holdrege, Charles T, Camillus. Intermediates useful in the prepara- tion of synthetic penicillins (P:. CA 966853, 1975-04 29.
  • 7Willner D, Dewitt, N Y. Antibacterial 3-(azidomethyl)-7-(a- aminophenyi (or thienyI; acetamido) ceph-3 em4-oic Acids (P]. US 3634418, 1972 01-11.
  • 8Simon S S, Lin C-CC. Process for preparation of 2-chloropheny lglycine derivatives and enantiomerically separation (P). US 20040176637, 2004-09-09.
  • 9Daniel A, Claude F, Maffrand J-P. Thieno (3, 2 e) pyridine derivatives and their theutic application (P). US 4529596, 1985-07-16.
  • 10Campo G, Fileti L, Nicoletta de Cesare, et al. Long-term clini- cal outcome based on aspirin and elopidogrel responsiveness sta- tus after elective pereutaneous coronary intervention [J]. Jour- nal of the American College of Cardiology, 2010, 56z 1447- 1455.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部